...
首页> 外文期刊>Melanoma research >Predictive role of preoperative lymphoscintigraphy on the status of the sentinel lymph node in clinically node-negative patients with cutaneous melanoma.
【24h】

Predictive role of preoperative lymphoscintigraphy on the status of the sentinel lymph node in clinically node-negative patients with cutaneous melanoma.

机译:临床淋巴结阴性皮肤黑素瘤患者术前淋巴闪烁照相术对前哨淋巴结状况的预测作用。

获取原文
获取原文并翻译 | 示例

摘要

We reviewed our experience to assess the predictive role of preoperative lymphoscintigraphy with regard to the pathological status of sentinel lymph node (sN) in patients with cutaneous melanoma, to optimize the surgical treatment planning with regard to the use of intraoperative frozen section examination of sN. Eighty-eight patients with clinically node-negative cutaneous melanoma pT1b-T4 stage underwent preoperative lymphoscintigraphy for the lymphatic mapping of sN. A lymphoscintigraphic 'score' (from L1 to L5) was developed based on the ratio of radiotracer concentration within sN nodes as compared with the injection site. Our score allowed us to foresee that sN of patients with thick melanomas (T3 and T4) and a low preoperative score (L1-L2-L3) had a 90% expected likelihood (P<0.001) of harboring metastasis, whereas sN in patients with thin melanomas (T1b-T2) and high preoperative score (from L4 to L5) showed a 100% likelihood of being metastasis free. In conclusion, the sN is a reliable predictor of regional lymph node status in patients with cutaneous malignant melanoma. Moreover, we suggest that a low score (L1-L2-L3) associated with a thick melanoma is a good predictive factor of the positive sN involvement. This information could be useful in scheduling the intraoperative frozen-section examination with an expected benefit of a positive test in almost 90% of patients. Such patients might be selected for a 'one-stage' procedure with a more effective cost/benefit ratio and decreased hospitalization costs.
机译:我们回顾了我们的经验,以评估术前淋巴闪烁成像对皮肤黑色素瘤患者前哨淋巴结(sN)病理状态的预测作用,以就术中冰冻切片检查sN的使用优化手术治疗计划。八十八例临床上淋巴结阴性的皮肤黑色素瘤pT1b-T4期患者接受了术前淋巴闪烁显像,用于sN的淋巴定位。根据sN淋巴结中的放射性示踪剂浓度与注射部位的比例,开发了一个淋巴描记术“分数”(从L1到L5)。我们的评分使我们可以预见,厚黑色素瘤(T3和T4)和术前评分低(L1-L2-L3)的患者的sN有90%的预期转移可能性(P <0.001),而sN在患有黑色素瘤的患者中薄的黑色素瘤(T1b-T2)和高术前评分(从L4到L5)显示无转移的可能性为100%。总之,sN是皮肤恶性黑色素瘤患者区域淋巴结状态的可靠预测指标。此外,我们建议与较厚的黑色素瘤相关的低分(L1-L2-L3)是sN阳性参与的良好预测因素。该信息可能有助于安排术中冰冻切片检查的时间,预期将对90%的患者进行阳性检测。可以选择此类患者进行“一阶段”手术,以提高成本/收益比并降低住院费用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号